Chalkis Health Industry Co (000972) Fair Value & Analysis
Consumer Defensive · CN · Market cap 2.8B CNY
Fair value as of: Jul 21, 2026
From 15 valuation models · updated 21 days ago
Share price −3.1% over the past month.
A solid business, but screening 22% overvalued on our models.
What matters now
- Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.
- Our model range runs from ¥2.08 (bear) to ¥3.49 (bull), base ¥2.71. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 53/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range ¥1.57 – ¥5.17 · fair‑value band ¥2.08 – ¥3.49 · the ¥3.47 price screens above the ¥2.71 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
Chalkis Health Industry Co (000972) currently trades at ¥3.47, while our model-based Fair Value estimate is ¥2.71, implying the stock looks roughly 21.9% overvalued today. The Quality Score stands at 53/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Chalkis Health Industry Co generated revenue of 468M CNY at a net margin of -12.5%. Revenue declined 30.3% year over year. Net debt stands at 318M CNY. Fundamentals as of Jul 21, 2026
Our scenario range runs from ¥2.08 (bear case) to ¥3.49 (bull case); at ¥3.47, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 33% below its 52-week high and 20% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at -22%, 000972 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 15 models by family
Widest divergence: DCF Models (¥4.67) versus Asset-Based (¥0.0200). Highest evidence: Growth DCF (80).
Notify me when 000972 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 54 · Market factors (momentum, volatility) 41
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Chalkis Health Industry Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of tomatoes in China and internationally. The company offers tomato sauces, lycopene vitamin E soft capsules, tomato cubes, peeled whole tomatoes, and tomato and sea buckthorn compressed candies.
Full company description
Chalkis Health Industry Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of tomatoes in China and internationally. The company offers tomato sauces, lycopene vitamin E soft capsules, tomato cubes, peeled whole tomatoes, and tomato and sea buckthorn compressed candies. It sells its products through online and offline channels. The company also engages in the planting of tomatoes; processing of agricultural products; technological development; tender brokerage; investment management; research and trial development; wholesale trade; agriculture; retail; and science and technology promotion and application activities. The company was formerly known as Xinjiang Chalkis Co., Ltd. and changed its name to Chalkis Health Industry Co., Ltd. in May 2016. Chalkis Health Industry Co., Ltd. was founded in 1994 and is headquartered in Wujiaqu, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Chalkis Health Industry Co reported revenue of ¥492M in FY2025 versus ¥174M in FY2021, a compound +29.6%/yr. Reported net income was −¥46.2M in FY2025.
000972 screens 22% overvalued. Compare with Nestlé India Limited →
Peer Group
Packaged Foods · 648 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé India Limited NESTLEIND | ₹1,427 | ₹362.37 | -75% |
| Britannia Industries Limited BRITANNIA | ₹5,413 | ₹1,870 | -65% |
| Tata Consumer Products Limited TATACONSUM | ₹1,089 | ₹327.27 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,650 IDR | 15,757 IDR | +137% |
| Samyang Foods Co 003230 | 1,139,000 KRW | 1,010,543 KRW | -11% |
| Patanjali Foods Limited PATANJALI | ₹413.80 | ₹157.04 | -62% |
| Vietnam Dairy Products Joint Stock Company VNM | 58,500 VND | 68,259 VND | +17% |
| PT Mayora Indah Tbk, MYOR | 1,750 IDR | 2,699 IDR | +54% |
| PT Cisarua Mountain Dairy Tbk CMRY | 4,490 IDR | 4,355 IDR | -3% |
| Nongshim Co 004370 | 348,500 KRW | 530,619 KRW | +52% |
Compare Chalkis Health Industry Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Chalkis Health Industry Co (000972) overvalued or undervalued?
What is the fair value of 000972?
What is the quality score of 000972?
What is the revenue of Chalkis Health Industry Co (000972)?
What is the net profit margin of 000972?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Chalkis Health Industry Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.